These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10577988)

  • 1. The role of TNFalpha and lymphotoxin in demyelinating disease.
    Lock C; Oksenberg J; Steinman L
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I121-8. PubMed ID: 10577988
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytotoxic cytokines in multiple sclerosis].
    Głabiński A
    Neurol Neurochir Pol; 1993; 27(6):869-75. PubMed ID: 8164782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astroglial-derived lymphotoxin-alpha exacerbates inflammation and demyelination, but not remyelination.
    Plant SR; Arnett HA; Ting JP
    Glia; 2005 Jan; 49(1):1-14. PubMed ID: 15382206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic aspects of multiple sclerosis.
    Taylor RS
    Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):525-36, v. PubMed ID: 9894106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour necrosis factor and lymphotoxin: molecular aspects and role in tissue-specific autoimmunity.
    Körner H; Sedgwick JD
    Immunol Cell Biol; 1996 Oct; 74(5):465-72. PubMed ID: 8912010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNFalpha: kill or cure for demyelinating disease?
    Finsen B; Antel J; Owens T
    Mol Psychiatry; 2002; 7(8):820-1. PubMed ID: 12232770
    [No Abstract]   [Full Text] [Related]  

  • 7. Demyelination and other neurological adverse events after anti-TNF therapy.
    Kaltsonoudis E; Voulgari PV; Konitsiotis S; Drosos AA
    Autoimmun Rev; 2014 Jan; 13(1):54-8. PubMed ID: 24035809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor-alpha and lymphotoxin-alpha in the pathology of experimental autoimmune encephalomyelitis: is either one responsible or is there another ligand-mediating disease?
    Willenborg DO; Fordham SA; O'Brien NC; Cowden WB; Ramshaw IA
    Res Immunol; 1998; 149(9):804-10; discussion 849-50, 855-60. PubMed ID: 9923636
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of tumor necrosis factor and lymphotoxin in lymphoid organ development.
    Ettinger R
    Curr Top Microbiol Immunol; 2000; 251():203-10. PubMed ID: 11036777
    [No Abstract]   [Full Text] [Related]  

  • 10. The presence of antibodies to lymphotoxin and tumor necrosis factor in normal serum.
    Jeffes EW; Ininns EK; Schmitz KL; Yamamoto RS; Dett CA; Granger GA
    Arthritis Rheum; 1989 Sep; 32(9):1148-52. PubMed ID: 2789046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic models for CNS inflammation.
    Owens T; Wekerle H; Antel J
    Nat Med; 2001 Feb; 7(2):161-6. PubMed ID: 11175845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF and viruses: multiple interrelationships.
    Rubin BY
    Immunol Ser; 1992; 56():331-40. PubMed ID: 1550867
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumour necrosis factor and anti-tumour necrosis factor approach to inflammatory demyelinating diseases of the central nervous system.
    Selmaj KW
    Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i94-102. PubMed ID: 11053098
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolongation of hepatic allograft survival in rat recipients treated with anti-lymphotoxin antibody.
    Teramoto K; Baquerizo A; Imagawa DK; Seu P; Hart J; Dempsey RA; Terasaki PI; Kamada N; Busuttil RW
    Transplant Proc; 1991 Feb; 23(1 Pt 1):602-3. PubMed ID: 1990621
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphotoxin and tumour necrosis factor as possible mediators of an inflammatory response.
    Ciba Found Symp; 1987; 131():185-91. PubMed ID: 3330010
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque.
    Raine CS; Bonetti B; Cannella B
    Rev Neurol (Paris); 1998 Sep; 154(8-9):577-85. PubMed ID: 9809372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Necrosis Factor and Lymphotoxin in Regulation of Intestinal Inflammation.
    Gubernatorova EO; Tumanov AV
    Biochemistry (Mosc); 2016 Nov; 81(11):1309-1325. PubMed ID: 27914457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytokines--polyfunctional regulators of protective reactions in normal and pathological states].
    Viadro MM; Navashin SM
    Antibiot Khimioter; 1989 Nov; 34(11):863-9. PubMed ID: 2699218
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of cellular immunity in multiple sclerosis].
    Caputo D; Zibetti A; Manara F; Bisaccia G
    Minerva Med; 1977 Feb; 68(6):413-6. PubMed ID: 300150
    [No Abstract]   [Full Text] [Related]  

  • 20. Demyelinating antibodies in multiple sclerosis.
    Seil FJ
    Ann Neurol; 2000 Dec; 48(6):948. PubMed ID: 11117555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.